Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D.
Transplantation Proceedings 27(1): 948-950
1995
ISSN/ISBN: 0041-1345 PMID: 7879242 Document Number: 441047
Document emailed within 1 workday
Related Documents
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410Carreño, V.; Porres, J.C.; Ruiz-Moreno, M.; Gutiez, J.; Bartolomé, F.J. 1991: A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 24-28
Utili, R.; Sagnelli, E.; Galanti, B.; Aprea, L.; Cesaro, G.; Digilio, L.; Filippini, P.; Felaco, F.M.; Gaeta, G.B.; Marrone, A. 1991: Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study American Journal of Gastroenterology 86(3): 327-330
Perrillo, R.P.; Regenstein, F.G.; Peters, M.G.; DeSchryver-Kecskemeti, K.; Bodicky, C.J.; Campbell, C.R.; Kuhns, M.C. 1988: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial Annals of Internal Medicine 109(2): 95-100
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Contreras, J.L.; Eckhoff, D.E.; Cartner, S.; Frenette, L.; Thomas, F.T.; Robbin, M.L.; Neville, D.M.; Thomas, J.M. 1999: Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients Transplantation 68(2): 215-219
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Arase, Y. 2006: Side effects of interferon therapy for chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1363-1367
Elefsiniotis, I.S.; Fotos, N.V.; Pantazis, K.D.; Papadeli, D.; Mavrogiannis, C. 2007: Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study Hepato-Gastroenterology 54(75): 2 PPreceding Table of Contents
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Waked, I.; Amin, M.; Abd-el Fattah, S.A.; Osman, L.; Sabbour, M. 1988: Interferon in chronic active hepatitis B. Preliminary results Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(3): 198-202
Tsuji, H.; Murai, K.; Akagi, K.; Fujishima, M. 1990: Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B Clinical Chemistry 36(6): 913-916
Bonaccorso, R.; Teresi, M.; Gebbia, V.; Tambone Reyes, M.; Tinnirello, D.; Di Marco, P.; Citarrella, P.; Mansueto, S. 1989: Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders Journal of ChemoTherapy 1(4 Suppl): 1266-1268
Siegert, W.; Nerl, C.; Meuthen, I.; Zahn, T.; Brack, N.; Lennert, K.; Huhn, D. 1991: Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients Leukemia 5(10): 892-895
Koda, N.; Oda, T.; Yokoyama, M.; Matsumoto, A.; Takeuchi, M. 1990: Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients Transplantation Proceedings 22(5): 2373-2375
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Matei, I.; Tănăsescu, C.; Voiosu, R.; Murariu, E.; Dragomir, P.; Serbănescu, A. 1998: Treatment with alpha-interferon in chronic hepatitis Romanian Journal of Internal Medicine 36(3-4): 227-237